Galaxy Surfactants Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 31 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹7.1K Cr
Q1 FY '27 volume growth guidance: 6% to 8%, targeting higher end of the range (Page 15). Q1 FY '27 volume growth guidance: 6% to 8%; EBITDA per metric ton expected at upper band (~INR 21,000).
From Galaxy Surfactants Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹2,333
Market Cap
₹7.1K Cr
P/E Ratio
25.6
How does Galaxy Surfactants Ltd rank in Chemicals & Petrochemicals?
Compare Galaxy Surfactants Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Galaxy Surfactants Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net profit ₹62 Cr.
Full financials →📊 Revenue & Sales Performance
- →Q1 FY '27 volume growth guidance: 6% to 8%, targeting higher end of the range (Page 15).
- →EBITDA per metric ton expected to improve to INR 21,000 (Page 15).
- →Specialty Ingredients focus likely to drive medium to long-term growth with capacities commissioned in last 1.5 years expected to contribute from FY '27 onwards (Page 13).
- →India market volume growth outlook: 8%-10% possible, subject to monsoon and energy prices impacting demand (Page 14).
- →AMET market volumes (~3%-4%) have bottomed out and expected to improve from coming quarters (Page 17).
- →Potential volume restocking in AMET post geopolitical resolution could spur growth (Page 12).
- →No new major growth capex planned in FY '27; focus on brownfield and maintenance capex (Page 15).
- →Optimism about sequential quarterly improvement barring unforeseen events (Page 5).
📈 Profitability & Margins
- →Q1 FY '27 volume growth guidance: 6% to 8%; EBITDA per metric ton expected at upper band (~INR 21,000).
- →Confidence in sequential quarterly improvement barring unforeseen events; cautious optimism due to macro uncertainties.
- →Specialty Ingredients expected to grow, with Specialty mix targeted around 60%-40% to 65%-35% (Specialty Ingredients vs. Performance Surfactants) by 2031.
- →EBITDA per metric ton targeted to improve towards INR 25,000 by 2029-30 as per Analyst Day projections.
- →Growth investments primarily in Specialty Ingredients; capex mainly routine and brownfield in FY '27, no major new commitments.
- →Potential upside from resolving geopolitical and supply chain challenges, especially in AMET and US markets, to accelerate volume and profitability growth.
- →Some margin pressure possible due to raw material price volatility but managed through repricing with customers.
🏗️ Capital Expenditure Plans
- →The company incurred around INR 480 crores of capex over the last 3 years, mainly focused on the Specialty Ingredients segment.
- →Maintenance capex is typically INR 20-30 crores per year.
- →Growth capex in recent years has been largely on specialty ingredients.
- →For FY '27, no major new growth capex commitments are planned; only routine or brownfield and replacement capex expected.
- →Some work-in-progress capex will get capitalized in FY '27, but no new large projects are planned.
- →The company is well-prepared to leverage existing capacities to capitalize on supply-side opportunities.
- →Specialty Ingredients segment investments include product launches (e.g., Lumithic) and building production pipelines.
- →Wellness segment initiatives are a work in progress and have not advanced as expected.
💰 Fundraising & Capital Structure
- →No explicit mention of any new fundraising through debt or equity in the transcript.
- →Current capital expenditure (capex) mainly maintenance-related or brownfield expansion, roughly INR20-30 crores per year.
- →No new growth capex commitments are planned for FY '27, only capitalization of work in progress and routine replacement capex.
- →Management has not indicated any plans for raising funds via equity or debt during the call.
- →Focus is on utilizing existing capacities and managing ongoing projects rather than financing new large-scale expansions.
- →Future outlook is cautious due to geopolitical and macroeconomic uncertainties, with no guidance suggesting fundraising activities.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Galaxy Surfactants Ltd Q4 FY26 results?
Q1 FY '27 volume growth guidance: 6% to 8%, targeting higher end of the range (Page 15). Q1 FY '27 volume growth guidance: 6% to 8%; EBITDA per metric ton expected at upper band (~INR 21,000).
What is Galaxy Surfactants Ltd share price analysis?
Galaxy Surfactants Ltd currently shows a neutral. The stock trades at a P/E of 25.6 with a market cap of ₹7,112 Cr. Investors should review the full earnings analysis for detailed insights.
Is Galaxy Surfactants Ltd planning capital expenditure?
The company incurred around INR 480 crores of capex over the last 3 years, mainly focused on the Specialty Ingredients segment.
Keep Galaxy Surfactants Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.